Invention Grant
- Patent Title: Histone demethylase inhibitors
-
Application No.: US14653821Application Date: 2013-12-23
-
Publication No.: US11639333B2Publication Date: 2023-05-02
- Inventor: Young K. Chen , Toufike Kanouni , Zhe Nie , Jeffrey Alan Stafford , James Marvin Veal , Michael Brennan Wallace
- Applicant: Quanticel Pharmaceuticals, Inc.
- Applicant Address: US CA San Diego
- Assignee: Quanticel Pharmaceuticals, Inc.
- Current Assignee: Quanticel Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Wiley Rein LLP
- International Application: PCT/US2013/077539 WO 20131223
- International Announcement: WO2014/100818 WO 20140626
- Main IPC: C07D405/14
- IPC: C07D405/14 ; C07D405/12 ; C07D213/79 ; C07D213/81 ; C07D401/04 ; C07D409/14 ; C07D213/74 ; C07D237/24 ; C07D401/12 ; C07D409/12

Abstract:
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted amidopyridine or amidopyridazine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
Public/Granted literature
- US20160115131A1 HISTONE DEMETHYLASE INHIBITORS Public/Granted day:2016-04-28
Information query